These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 1815451

  • 21. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG).
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [Abstract] [Full Text] [Related]

  • 22. Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A.
    Acta Paediatr Suppl; 1994 Dec; 406():18-23; discussion 24. PubMed ID: 7734807
    [Abstract] [Full Text] [Related]

  • 23. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
    Cutfield W, Lindberg A, Albertsson Wikland K, Chatelain P, Ranke MB, Wilton P.
    Acta Paediatr Suppl; 1999 Feb; 88(428):72-5. PubMed ID: 10102057
    [Abstract] [Full Text] [Related]

  • 24. Characteristics of children with idiopathic short stature in the Kabi Pharmacia International Growth Study, and their response to growth hormone treatment. International Board of the Kabi Pharmacia International Growth Study.
    Albertsson-Wikland K.
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():75-8. PubMed ID: 8219481
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.
    Price DA, Wilton P, Jönsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB.
    Horm Res; 1998 Sep; 49(2):91-7. PubMed ID: 9485178
    [Abstract] [Full Text] [Related]

  • 26. Final height in children with medulloblastoma treated with growth hormone.
    Ranke MB, Price DA, Lindberg A, Wilton P, Darendeliler F, Reiter EO.
    Horm Res; 2005 Sep; 64(1):28-34. PubMed ID: 16103682
    [Abstract] [Full Text] [Related]

  • 27. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).
    Ranke MB, Lindberg A, Cowell CT, Wikland KA, Reiter EO, Wilton P, Price DA, KIGS International Board.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):125-31. PubMed ID: 12519840
    [Abstract] [Full Text] [Related]

  • 28. [Growth hormone therapy in prepubertal children with chronic renal insufficiency].
    Kost'álová L, Misíková Z, Furková K, Lebl J, Simková E, Krásnicanová H.
    Cas Lek Cesk; 1995 Dec 13; 134(24):788-90. PubMed ID: 8599822
    [Abstract] [Full Text] [Related]

  • 29. Predicting growth response among Egyptian prepubertal idiopathic isolated growth hormone deficient children.
    Salah N, Abd El Dayem SM, Fawaz L, Ibrahim M.
    J Pediatr Endocrinol Metab; 2013 Dec 13; 26(3-4):247-55. PubMed ID: 23337051
    [Abstract] [Full Text] [Related]

  • 30. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM, Rikken B, Wynne HJ, Hokken-Koelega AC, Wit JM, Bot A, Drop SL.
    J Clin Endocrinol Metab; 1992 Apr 13; 74(4):898-905. PubMed ID: 1548357
    [Abstract] [Full Text] [Related]

  • 31. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z, Li YH, Ma HM, Chen HS, DU ML, Gu YF.
    Zhonghua Er Ke Za Zhi; 2008 Oct 13; 46(10):757-62. PubMed ID: 19099881
    [Abstract] [Full Text] [Related]

  • 32. Growth hormone secretion and the therapeutic effects of human growth hormone: first Japanese results of the Kabi Pharmacia International Growth Study/International Cooperative Growth Study.
    Tanaka T.
    Acta Paediatr Scand Suppl; 1991 Oct 13; 379():126-35. PubMed ID: 1815454
    [Abstract] [Full Text] [Related]

  • 33. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone.
    Chen YD, Shu SG, Chi CS.
    Acta Paediatr Taiwan; 2001 Oct 13; 42(5):291-6. PubMed ID: 11729706
    [Abstract] [Full Text] [Related]

  • 34. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO, Lindberg A, Ranke MB, Price DA, Albertsson-Wikland K, Cowell CT, Bakker B.
    Horm Res; 2003 Oct 13; 60(Suppl 1):68-73. PubMed ID: 12955021
    [Abstract] [Full Text] [Related]

  • 35. Catch-up growth after childhood-onset substitution in primary hypothyroidism: is it a guide towards optimal growth hormone treatment in idiopathic growth hormone deficiency?
    Ranke MB, Schwarze CP, Mohnike K, von Mühlendahl KE, Keller E, Willgerodt H, Kiess W.
    Horm Res; 1998 Oct 13; 50(5):264-70. PubMed ID: 9873194
    [Abstract] [Full Text] [Related]

  • 36. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA, KIGS International Board. Kabi International Growth Study.
    J Clin Endocrinol Metab; 2000 Nov 13; 85(11):4212-8. PubMed ID: 11095456
    [Abstract] [Full Text] [Related]

  • 37. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Ranke MB, Guilbaud O, Lindberg A, Cole T.
    Acta Paediatr Suppl; 1993 Sep 13; 82 Suppl 391():82-8; discussion 89. PubMed ID: 8219483
    [Abstract] [Full Text] [Related]

  • 38. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
    Darendeliler F, Berberoğlu M, Ocal G, Adiyaman P, Bundak R, Günöz H, Baş F, Darcan S, Gökşen D, Arslanoğlu I, Yildiz M, Ercan O, Ercan G, Ozerkan E, Can S, Böber E, Adal E, Sarikaya S, Dallar Y, Siklar Z, Bircan I, Bideci A, Yüksel B, Büyükgebiz A.
    J Pediatr Endocrinol Metab; 2005 Oct 13; 18(10):949-54. PubMed ID: 16355808
    [Abstract] [Full Text] [Related]

  • 39. [Growth hormone therapy in children with growth hormone deficiency: study of dose-response relationship].
    Lebl J, Zemková D, Kolousková S, Snajderová M.
    Cas Lek Cesk; 1994 Apr 18; 133(8):237-41. PubMed ID: 8194087
    [Abstract] [Full Text] [Related]

  • 40. Reference curve for the first-year growth response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency: validation of the KIGS first-year growth response curve using the Belgian Register for the Study of Growth and Puberty Problems.
    Straetemans S, Roelants M, Thomas M, Rooman R, De Schepper J.
    Horm Res Paediatr; 2014 Apr 18; 81(5):343-9. PubMed ID: 24686034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.